Last week, the state of California auto-renewed its controversial COVID-19 testing contract with PerkinElmer to run the Valencia Branch Laboratory. Designed, built, and operated by PerkinElmer, the lab began SARS-CoV-2 testing in the fall of 2020 and immediately was in the news for a range of issues. The original award was a no-bid contract worth as much as $1.7 billion to PerkinElmer.
MORE ON: Valencia COVID-19 Laboratory
To date, PerkinElmer has been paid $716 million to operate the Valencia Branch Laboratory, according to statements by Sami Gallegos, a spokesperson for the California Health and Human Services Agency. What is noteworthy for pathologists and lab managers is that, earlier this year, CalMatters wrote that “state health inspectors gave this lab an ‘immediate jeopardy’ designation—which represents ‘the most severe and egregious threat to the health and safety of recipients.’” California State officials promised to release the full report in March. Seven months later, that report has still not been released to the public.
ANY LAB TEST NOW MAKES LIST OF FASTEST-GROWING
For the sixth year in a row, Alpharetta-Ga.-based ANY LAB TEST NOW has made Entrepreneur’s 2021 Franchise 500 and Franchise 500 Best of the Best lists. The company serves consumers with a broad menu of clinical laboratory tests. It now has a network of 190 franchise locations throughout the United States. The multi-year growth of ANY LAB TEST NOW and its expanding network of franchises demonstrates that consumers are both interested in ordering their own clinical laboratory tests and are willing to pay cash for these tests.
•Agilent Technologies, Inc., of Santa Clara, Calif., appointed John Palma to the position of Vice President, Medical Affairs. Palma previous held executive positions at Roche, RedPath Integrated Pathology, Veridex, Affymetrix, and Metabolix.
• Steve Pemberton is the new Senior Vice President of Commercial Development at Cambridge, Mass.-based Ultivue. Prior executive positions were with Haematologic Technologies, Bionique Testing Laboratories, Rheonix, Ventana Medical Systems, and Abbott Laboratories.
• Enzo Biochem of New York announced the selection of Hamid R. Erfanian as its new CEO. Erfanian formerly held positions at Euroimmun, Diagnostica Stago, Beckman Coulter, Abbott Laboratories, Quest Diagnostics, PharmChem, Corning Clinical Laboratories, and Labcorp.
That’s all the insider intelligence for this report. Look for the next briefing on Monday, November 29, 2021.